the Effect of Roux-en-Y Gastrojejunostomy after Proximal Gastrectomy on Preventing Postoperative Reflux for Early Siewert II/III EGJ cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPC-15005984

Enrollment

Unknown

Registered

2015-02-14

Start date

2015-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

A:Roux-en-Y Gastrojejunostomy after Total Gastrectomy

B:Gastroesophagostomy after Proximal Gastrectomy

C:Roux-en-Y Gastrojejunostomy after Proximal Gastrectomy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients determined with early Siewert II/III gastric cancer by pathology; 2. patients without significant difference in basic features; 3. patients confirmed as phase I gastric cancer by endoscopic ultrasonography; 4. patients without metastasis and chemotherapy; 5. patients with capacity of answering the questionnaires; 6. patients without mental disease; 7. patients aged between 18 to 70; 8. patients without other disease which may affect the capacity of answering the questionnaires; 9. patients who are willing to participate this trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with active infection; 2. patients with pregnancy or lactation; 3. patients complicated with severe cardiovascular disease, hepatic or renal dysfunction, coagulation disorder, or mental disease; 4. patients participate multiple trials; 5. patients quit this trial once.

Design outcomes

Primary

Measure	Time frame
Quality of life;nutritional status;	—

Countries

China

Contacts

Public ContactZekuan Xu

xuzekuan@njmu.edu.cn+86 13809031818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026